institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published 3 days ago • loading... • Updated 3 days ago

China Prepares to Launch the Generic of Ozempic and Wegovy

Summary by La Vanguardia

The semaglutide, marketed by the Danish Novo Nordisk as Ozempic for diabetes and Wegovy for obesity, was ranked among the best-selling drugs worldwide in 2024. Although patents protect the medicine up to 2031-2032 in seven major markets, the Chinese patent expires much earlier, in March 2026.Continue reading...

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

China Prepares to Launch the Generic of Ozempic and Wegovy

The semaglutide, marketed by the Danish Novo Nordisk as Ozempic for diabetes and Wegovy for obesity, was ranked among the best-selling drugs worldwide in 2024. Although patents protect the medicine up to 2031-2032 in seven major markets, the Chinese patent expires much earlier, in March 2026.Continue reading...

3 days ago·Granada, Spain

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated3 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

La Vanguardia broke the news in Granada, Spain 3 days ago on Wednesday, September 3, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics